SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Wei-hui Liu, Li-na Ren, Xing Wang, Tao Wang, Ning Zhang, Yuan Gao, Hao Luo, Nalu Navarro-Alvarez, Li-jun Tang, Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats, Journal of Cancer Research and Clinical Oncology, 2015,

    CrossRef

  2. 2
    Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Epigenetic therapy as a novel approach in hepatocellular carcinoma, Pharmacology & Therapeutics, 2015, 145, 103

    CrossRef

  3. 3
    Shuxiang Hu, Ruiyang Tao, Shouyu Wang, Chaoqun Wang, Xiankun Zhao, Hua Zhao, Lijuan Li, Shaohua Zhu, Yan He, Xinghong Jiang, Yuzhen Gao, MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1, Tumor Biology, 2015,

    CrossRef

  4. 4
    E Callegari, L Gramantieri, M Domenicali, L D'Abundo, S Sabbioni, M Negrini, MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches, Cell Death and Differentiation, 2015, 22, 1, 46

    CrossRef

  5. 5
    Rui Wang, Jun Zhang, Weiru Jiang, Yanyun Ma, Wenshuai Li, Bohan Jin, Heping Hu, Jiucun Wang, Yi Liu, Jie Liu, Association between a Variant in MicroRNA-646 and the Susceptibility to Hepatocellular Carcinoma in a Large-Scale Population, The Scientific World Journal, 2014, 2014, 1

    CrossRef

  6. 6
    Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri, Biomarkers for virus-induced hepatocellular carcinoma (HCC), Infection, Genetics and Evolution, 2014, 26, 327

    CrossRef

  7. 7
    Qian He, Yongde Huang, Lei Cai, Shaobo Zhang, Chenghua Zhang, Expression and prognostic value of Ars2 in hepatocellular carcinoma, International Journal of Clinical Oncology, 2014, 19, 5, 880

    CrossRef

  8. 8
    Q Ruan, P Wang, T Wang, J Qi, M Wei, S Wang, T Fan, D Johnson, X Wan, W Shi, H Sun, Y H Chen, MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2, Cell Death and Disease, 2014, 5, 2, e1095

    CrossRef

  9. 9
    Gang Shen, Ye Lin, Xuewei Yang, Jing Zhang, Zhe Xu, Hongyun Jia, MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X, BMC Cancer, 2014, 14, 1, 393

    CrossRef

  10. 10
    Xiao Zhang, Shijie Hu, Xiang Zhang, Lei Wang, Xiaofang Zhang, Bo Yan, Jing Zhao, Angang Yang, Rui Zhang, MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells, Biochemical and Biophysical Research Communications, 2014, 443, 3, 1078

    CrossRef

  11. 11
    Hongmin Yin, Xinguo Peng, Peng Ren, Bo Cheng, Shumin Li, Chengyong Qin, MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis, Tumor Biology, 2014, 35, 12, 12317

    CrossRef

  12. 12
    Jennifer Bolleyn, Joery De Kock, Robim Marcelino Rodrigues, Mathieu Vinken, Vera Rogiers, Tamara Vanhaecke, MicroRNAs as key regulators of xenobiotic biotransformation and drug response, Archives of Toxicology, 2014,

    CrossRef

  13. 13
    Hua Wang, Bin Gao, MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops, Hepatology, 2014, 60, 5
  14. 14
    Qiong Li, Chenchen Ding, Chuan Chen, Zhimin Zhang, He Xiao, Fei Xie, Lin Lei, Yuanyuan Chen, Bijing Mao, Mei Jiang, Jian Li, Dong Wang, Ge Wang, miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2014, 29, 4
  15. 15
    Priyanka Gupta, Murray J Cairns, Nitin K Saksena, Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinoma, Virology Journal, 2014, 11, 1, 64

    CrossRef

  16. 16
    Megan L. Finch, Jens U. Marquardt, George C. Yeoh, Bernard A. Callus, Regulation of microRNAs and their role in liver development, regeneration and disease, The International Journal of Biochemistry & Cell Biology, 2014, 54, 288

    CrossRef

  17. 17
    Igor P. Pogribny, Ivan Rusyn, Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma, Cancer Letters, 2014, 342, 2, 223

    CrossRef

  18. 18
    Rafael Valencia-Quintana, Juana Sánchez-Alarcón, María G. Tenorio-Arvide, Youjun Deng, José M. R. Montiel-González, Sandra Gómez-Arroyo, Rafael Villalobos-Pietrini, Josefina Cortés-Eslava, Ana R. Flores-Márquez, Francisco Arenas-Huertero, The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review, Frontiers in Microbiology, 2014, 5,

    CrossRef

  19. 19
    Chong-Ling Duan, Gui-Hua Hou, Yan-Ping Liu, Ting Liang, Jing Song, Jian-Kui Han, Chao Zhang, Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma, Tumor Biology, 2014, 35, 12, 12205

    CrossRef

  20. 20
    Kaipeng Xie, Jibin Liu, Liguo Zhu, Yao Liu, Yun Pan, Juan Wen, Hongxia Ma, Xiangjun Zhai, Zhibin Hu, A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma, Cancer Epidemiology, 2013, 37, 6, 998

    CrossRef

  21. 21
    Ji-Young Jang, Young-Sin Lee, Yoon-Kyung Jeon, Kyoungbun Lee, Ja-June Jang, Chul-Woo Kim, ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma, Experimental & Molecular Medicine, 2013, 45, 1, e3

    CrossRef

  22. 22
    Rajagopal N. Aravalli, Erik N. K. Cressman, Clifford J. Steer, Cellular and molecular mechanisms of hepatocellular carcinoma: an update, Archives of Toxicology, 2013, 87, 2, 227

    CrossRef

  23. 23
    Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda, Takafumi Ichida, Clinical significance of cell cycle inhibitors in hepatocellular carcinoma, Medical Molecular Morphology, 2013, 46, 4, 185

    CrossRef

  24. 24
    Rajagopal Aravalli, Development of MicroRNA Therapeutics for Hepatocellular Carcinoma, Diagnostics, 2013, 3, 1, 170

    CrossRef

  25. 25
    Sandy Leung-Kuen Au, Irene Oi-Lin Ng, Chun-Ming Wong, Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins, Frontiers of Medicine, 2013, 7, 2, 231

    CrossRef

  26. 26
    Minhua Rong, Gang Chen, Yiwu Dang, Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro, BMC Cancer, 2013, 13, 1, 21

    CrossRef

  27. 27
    Yong Huang, You Bing Yang, Xiao Hui Zhang, Xue Li Yu, Zhan Bin Wang, Xiang Chao Cheng, MicroRNA-21 gene and cancer, Medical Oncology, 2013, 30, 1

    CrossRef

  28. 28
    Guangxian Xu, Yilin Zhang, Jun Wei, Wei Jia, Zhaohui Ge, Zhaobo Zhang, Xiaoming Liu, MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3, BMC Cancer, 2013, 13, 1, 469

    CrossRef

  29. 29
    J A Ronald, R Katzenberg, C H Nielsen, H J Jae, L V Hofmann, S S Gambhir, MicroRNA-regulated non-viral vectors with improved tumor specificity in an orthotopic rat model of hepatocellular carcinoma, Gene Therapy, 2013, 20, 10, 1006

    CrossRef

  30. 30
    Qinggong Yuan, Komal Loya, Bhavna Rani, Selina Möbus, Asha Balakrishnan, Jutta Lamle, Toni Cathomen, Arndt Vogel, Michael P. Manns, Michael Ott, Tobias Cantz, Amar Deep Sharma, MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration, Hepatology, 2013, 57, 1
  31. 31
    Heping Yang, Michele E. Cho, Tony W.H. Li, Hui Peng, Kwang Suk Ko, Jose M. Mato, Shelly C. Lu, MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma, Journal of Clinical Investigation, 2013, 123, 1, 285

    CrossRef

  32. 32
    Chuan-Chun Lee, Chia-Jui Yen, Tsunglin Liu, Prediction of personalized microRNA activity, Gene, 2013, 518, 1, 101

    CrossRef

  33. 33
    Bo-an Li, A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma, Acta Pharmacologica Sinica, 2012, 33, 1, 3

    CrossRef

  34. 34
    Joon Seol Bae, Jeong-Hyun Kim, Charisse Flerida A. Pasaje, Hyun Sub Cheong, Tae Hoon Lee, In Song Koh, Hyo-Suk Lee, Yoon Jun Kim, Hyoung Doo Shin, Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases, Digestive and Liver Disease, 2012, 44, 10, 849

    CrossRef

  35. 35
    Won Hee Kim, Kyung Tae Min, Young Joo Jeon, Chang-Il Kwon, Kwang Hyun Ko, Pil Won Park, Sung Pyo Hong, Kyu Seong Rim, Sung Won Kwon, Seong Gyu Hwang, Nam Keun Kim, Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population, Gene, 2012, 504, 1, 92

    CrossRef

  36. 36
    Monika Kwiecinski, Natalia Elfimova, Andrea Noetel, Ulrich Töx, Hans-Michael Steffen, Ulrich Hacker, Roswitha Nischt, Hans Peter Dienes, Margarete Odenthal, Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29, Laboratory Investigation, 2012, 92, 7, 978

    CrossRef

  37. 37
    Marion Martin, Zdenko Herceg, From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms, Genome Medicine, 2012, 4, 1, 8

    CrossRef

  38. 38
    Lucy Lim, Bang Manh Tran, Elizabeth Vincan, Stephen Locarnini, Nadia Warner, HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA, Future Virology, 2012, 7, 12, 1237

    CrossRef

  39. 39
    Ning Ma, Fuyuan Li, Dan Li, Yang Hui, Xidi Wang, Yu Qiao, Yanfen Zhang, Ying Xiang, Jianying Zhou, Lingyun Zhou, Xiaofei Zheng, Xu Gao, Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation, Molecular and Cellular Biochemistry, 2012, 361, 1-2, 337

    CrossRef

  40. 40
    Francesca Fornari, Maddalena Milazzo, Pasquale Chieco, Massimo Negrini, Elena Marasco, Giovanni Capranico, Vilma Mantovani, Jessica Marinello, Silvia Sabbioni, Elisa Callegari, Matteo Cescon, Matteo Ravaioli, Carlo M Croce, Luigi Bolondi, Laura Gramantieri, In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2, The Journal of Pathology, 2012, 227, 3
  41. 41
    Tsung-Chieh Shih, Yin-Jing Tien, Chih-Jen Wen, Ta-Sen Yeh, Ming-Chin Yu, Chia-Hao Huang, Yun-Shien Lee, Tzu-Chen Yen, Sen-Yung Hsieh, MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma, Journal of Hepatology, 2012, 57, 3, 584

    CrossRef

  42. 42
    X-X He, Y Chang, F-Y Meng, M-Y Wang, Q-H Xie, F Tang, P-Y Li, Y-H Song, J-S Lin, MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo, Oncogene, 2012, 31, 28, 3357

    CrossRef

  43. 43
    S Zhang, C Shan, G Kong, Y Du, L Ye, X Zhang, MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK), Oncogene, 2012, 31, 31, 3607

    CrossRef

  44. 44
    Jie Xu, Xiuming Zhu, Lingjiao Wu, Rong Yang, Zeran Yang, Qiangfeng Wang, Fusheng Wu, MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway, Liver International, 2012, 32, 5
  45. 45
    Ying Chang, Wei Yan, Xingxing He, Lemeng Zhang, Chuanjiang Li, Hai Huang, Gary Nace, David A. Geller, Jusheng Lin, Allan Tsung, miR-375 Inhibits Autophagy and Reduces Viability of Hepatocellular Carcinoma Cells Under Hypoxic Conditions, Gastroenterology, 2012, 143, 1, 177

    CrossRef

  46. 46
    Igor P. Pogribny, S. Jill James, Frederick A. Beland, Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency, Molecular Nutrition & Food Research, 2012, 56, 1
  47. 47
    Stine B. Thorsen, Susanna Obad, Niels F. Jensen, Jan Stenvang, Sakari Kauppinen, The Therapeutic Potential of MicroRNAs in Cancer, The Cancer Journal, 2012, 18, 3, 275

    CrossRef

  48. 48
    Zdenko Herceg, Anupam Paliwal, Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome, Mutation Research/Reviews in Mutation Research, 2011, 727, 3, 55

    CrossRef

  49. 49
    Luigi Bolondi, Laura Gramantieri, From liver cirrhosis to HCC, Internal and Emergency Medicine, 2011, 6, S1, 93

    CrossRef

  50. 50
    Fei-Fei Lan, Hua Wang, Yang-Chao Chen, Chu-Yan Chan, Samuel S. Ng, Kui Li, Dan Xie, Ming-Liang He, Marie C. Lin, Hsiang-Fu Kung, Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16INK4A, International Journal of Cancer, 2011, 128, 2
  51. 51
    Jin Hou, Li Lin, Weiping Zhou, Zhengxin Wang, Guoshan Ding, Qiongzhu Dong, Lunxiu Qin, Xiaobing Wu, Yuanyuan Zheng, Yun Yang, Wei Tian, Qian Zhang, Chunmei Wang, Qinghua Zhang, Shi-Mei Zhuang, Limin Zheng, Anmin Liang, Wenzhao Tao, Xuetao Cao, Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma, Cancer Cell, 2011, 19, 2, 232

    CrossRef

  52. 52
    Saswati Paul, Seung Jun Kim, Hye-Won Park, Seung Yong Lee, Yu Ri An, Moon-Ju Oh, Jin Wook Jung, Jae-Chun Ryu, Seung Yong Hwang, Impact of miRNA deregulation on mRNA expression profiles in response to environmental toxicant, nonylphenol, Molecular & Cellular Toxicology, 2011, 7, 3, 259

    CrossRef

  53. 53
    Nicole C. Panarelli, Rhonda K. Yantiss, MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract, Pathology Research International, 2011, 2011, 1

    CrossRef

  54. 54
    Bahaeldin K. Elamin, Elisa Callegari, Laura Gramantieri, Silvia Sabbioni, Massimo Negrini, MicroRNA response to environmental mutagens in liver, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011, 717, 1-2, 67

    CrossRef

  55. 55
    Yan-Yan Hou, Wei-Wei Cao, Lan Li, Sheng-Ping Li, Tao Liu, Hai-Ying Wan, Min Liu, Xin Li, Hua Tang, MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703, Cancer Letters, 2011, 307, 2, 182

    CrossRef

  56. 56
    Xiao-Hui Huang, Jing-Song Chen, Qian Wang, Xi-Lin Chen, Li Wen, Lian-Zhou Chen, Jiong Bi, Long-Juan Zhang, Qiao Su, Wen-Tao Zeng, miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened, The Journal of Pathology, 2011, 225, 3
  57. 57
    H. van Malenstein, J. van Pelt, C. Verslype, Molecular classification of hepatocellular carcinoma anno 2011, European Journal of Cancer, 2011, 47, 12, 1789

    CrossRef

  58. 58
    Hai-Liang Zhang, Li-Feng Yang, Yao Zhu, Xu-Dong Yao, Shi-Lin Zhang, Bo Dai, Yi-Ping Zhu, Yi-Jun Shen, Guo-Hai Shi, Ding-Wei Ye, Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy, The Prostate, 2011, 71, 3
  59. 59
    Ji-hang Yuan, Fu Yang, Bi-feng Chen, Zhi Lu, Xi-song Huo, Wei-ping Zhou, Fang Wang, Shu-han Sun, The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma, Hepatology, 2011, 54, 6
  60. 60
    Q. Ruan, T. Wang, V. Kameswaran, Q. Wei, D. S. Johnson, F. Matschinsky, W. Shi, Y. H. Chen, The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic   cell death, Proceedings of the National Academy of Sciences, 2011, 108, 29, 12030

    CrossRef

  61. 61
    Hiroaki Ohdaira, Kenichi Yoshida, OMICS, 2011,

    CrossRef

  62. 62
    Athena Starlard-Davenport, Volodymyr Tryndyak, Oksana Kosyk, Sharon R. Ross, Ivan Rusyn, Frederick A. Beland, Igor P. Pogribny, Dietary Methyl Deficiency, microRNA Expression and Susceptibility to Liver Carcinogenesis, Journal of Nutrigenetics and Nutrigenomics, 2010, 3, 4-6, 259

    CrossRef

  63. 63
    Zong-Fang Li, Juan Wang, Chen Huang, Shu Zhang, Jun Yang, An Jiang, Rui Zhou, Dun Pan, Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis, Rapid Communications in Mass Spectrometry, 2010, 24, 18
  64. 64
    S. K. Das, U. K. Sokhi, S. K. Bhutia, B. Azab, Z.-z. Su, D. Sarkar, P. B. Fisher, Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells, Proceedings of the National Academy of Sciences, 2010, 107, 26, 11948

    CrossRef

  65. 65
    Li-Hsin Chen, Kun-Ling Tsai, Yi-Wei Chen, Cheng-Chia Yu, Kuo-Wei Chang, Shi-Hwa Chiou, Hung-Hai Ku, Pen-Yuan Chu, Ling-Ming Tseng, Pin-I Huang, Wen-Liang Lo, MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma, Journal of Oncology, 2010, 2010, 1

    CrossRef

  66. 66
    J Zhang, Y Yang, T Yang, Y Liu, A Li, S Fu, M Wu, Z Pan, W Zhou, microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity, British Journal of Cancer, 2010, 103, 8, 1215

    CrossRef

  67. 67
    Jon C. Henry, Jong-Kook Park, Jinmai Jiang, Ji Hye Kim, David M. Nagorney, Lewis R. Roberts, Soma Banerjee, Thomas D. Schmittgen, miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines, Biochemical and Biophysical Research Communications, 2010, 403, 1, 120

    CrossRef

  68. 68
    Maddalena Frau, Fiorella Biasi, Francesco Feo, Rosa M. Pascale, Prognostic markers and putative therapeutic targets for hepatocellular carcinoma, Molecular Aspects of Medicine, 2010, 31, 2, 179

    CrossRef

  69. 69
    Xiao-Feng Le, Omar Merchant, Robert C. Bast, George A. Calin, The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade, Cancer Microenvironment, 2010, 3, 1, 137

    CrossRef

  70. 70
    Igor P Pogribny, MicroRNA dysregulation during chemical carcinogenesis, Epigenomics, 2009, 1, 2, 281

    CrossRef

  71. 71
    Kai Ruan, Xiaoguang Fang, Gaoliang Ouyang, MicroRNAs: Novel regulators in the hallmarks of human cancer, Cancer Letters, 2009, 285, 2, 116

    CrossRef

  72. 72
    Xuelian Zhao, Lynne W Elmore, Curtis C Harris, Xin Wei Wang, Hepatocellular Carcinoma, eLS,
  73. 73
    D.S. Karolina, K. Jeyaseelan, micro RNAs as Therapeutic Agents and Targets,
  74. 74
    Zhaojian Gong, Zhaoyang Zeng, Pranab Behari Mazumder, Jian Ma, Ming Zhou, Xiayu Li, Xiaoling Li, Wei Xiong, Yong Li, Guiyuan Li, MicroRNA and Inflammation-Related Cancer,